About RefleXion
RefleXion is a company based in Hayward (United States) founded in 2009 by Samuel Mazin. RefleXion has raised $553.91 million across 18 funding rounds from investors including Pfizer, Johnson & Johnson and T. Rowe Price. RefleXion offers products and services including SCINTIX Therapy and RefleXion X1. RefleXion operates in a competitive market with competitors including Alpha Tau Medical, Mevion Medical Systems, ZAP-X, Starget Pharma and Leo Cancer Care, among others.
- Headquarter Hayward, United States
- Founders Samuel Mazin
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Reflexion Medical
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$553.91 M (USD)
in 18 rounds
-
Latest Funding Round
$106.71 M (USD), Series F
Nov 13, 2023
-
Investors
Pfizer
& 20 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of RefleXion
RefleXion offers a comprehensive portfolio of products and services, including SCINTIX Therapy and RefleXion X1.
Utilizes cancer emissions for real-time tumor tracking and treatment.
Combines PET imaging with radiotherapy to target moving tumors.
People of RefleXion
Unlock access to complete
Unlock access to complete
Funding Insights of RefleXion
RefleXion has successfully raised a total of $553.91M across 18 strategic funding rounds. The most recent funding activity was a Series F round of $106.71 million completed in November 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in RefleXion
RefleXion has secured backing from 21 investors, including venture fund and institutional investors. Prominent investors backing the company include Pfizer, Johnson & Johnson and T. Rowe Price.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Sector-agnostic VC investment company investing globally
|
Locked | Locked | Locked | |
|
Private equity and hedge fund investments in healthcare are managed.
|
Locked | Locked | Locked | |
|
Venture capital firm focused on tech sectors
|
Locked | Locked | Locked |
Investor details for RefleXion
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by RefleXion
Investment portfolio details for RefleXion
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - RefleXion
Detailed financials for RefleXion
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Reflexion Comparisons
Peer comparison for RefleXion
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of RefleXion
RefleXion operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Alpha Tau Medical, Mevion Medical Systems, ZAP-X, Starget Pharma and Leo Cancer Care, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Radiotherapy technique for solid tumors is developed using alpha-emitting seeds.
|
|
| Locked | Locked | Locked |
Proton therapy systems are supplied for cancer radiation treatment.
|
|
| Locked | Locked | Locked |
Developer of gyroscopic radiosurgery platform
|
|
| Locked | Locked | Locked |
Targeted radiopharmaceuticals are developed for solid tumor treatment.
|
|
| Locked | Locked | Locked |
Advanced radiotherapy devices for cancer treatment are developed.
|
Detailed competitors of RefleXion
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Reflexion
Complete news archive for RefleXion
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about RefleXion
RefleXion was founded in 2009 and raised its 1st funding round 1 year after it was founded.
RefleXion is headquartered in Hayward, United States. It is registered at Hayward, California, United States.
Todd Powell is the current CEO of RefleXion.
RefleXion is a funded company, having raised a total of $553.91M across 18 funding rounds to date.
RefleXion was founded in 2009 and is headquartered in Hayward, United States. The company operates in the medical technology sector, focusing on radiotherapy solutions. Its technology integrates Positron Emission Tomography to enable real-time tumor tracking and personalized radiation delivery. Applications target lung, prostate, and breast cancers, supporting precise treatment processes in oncology care.
RefleXion's top competitors include Alpha Tau Medical, Starget Pharma and ABK Biomedical.
RefleXion offers SCINTIX Therapy and RefleXion X1.
RefleXion has 21 investors. Key investors include Pfizer, Johnson & Johnson, T. Rowe Price, HHS, and Hillenbrand.